Immunology in drug research.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-3-0348-7118-1_7PMID 6091176
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biological effects of cyclosporin A: A new antilymphocytic agent

  2005cited by this paper
• Inhibition of arachidonic acid cyclo-oxygenase and lipoxygenase activities of leukocytes by indomethacin and compound BW755C

  2005cited by this paper
• Inhibition of oxidative enzymes by anti-allergy drugs

  2005cited by this paper
• In vivo interleukin 2 administration augments the generation of alloreactive cytolytic T lymphocytes and resident natural killer cells.

  1983cited by this paper
• PROSTAGLANDIN AS AN EFFECTIVE ANTIREJECTION THERAPY IN RAT RENAL ALLOGRAFT RECIPIENTS

  1983cited by this paper
• The activity of a new, novel inhibitor of leukotriene synthesis in rhesus monkey Ascaris reactors.

  1983cited by this paper
• A practical approach to cagebirds

  1983cited by this paper
• Adriamycin induced immunomodulation: dependence upon time of administration.

  1983cited by this paper
• Direct demonstration of the human suppressor inducer subset by anti-T cell antibodies.

  1983cited by this paper
• Inhibition of leukotriene biosynthesis in mastocytoma cells by diethylcarbamazine.

  1982cited by this paper
• Immunohistological studies of the thymus in myasthenia gravis. Correlation with clinical state and thymocyte culture responses.

  1982cited by this paper
• Some thoughts on idiotypic networks and immunoregulation.

  1982cited by this paper
• 6,9-deepoxy-6,9,-(phenylimino)-delta 6,8-prostaglandin I1, (U-60,257), a new inhibitor of leukotriene C and D synthesis: in vitro studies.

  1982cited by this paper
• Niridazole and fertility in bilharzial men.

  1982cited by this paper
• ENHANCED KIDNEY GRAFT SURVIVAL WITH RETROPLACENTAL SOURCE γ‐GLOBULIN: RESULTS OF A 5‐YEAR PROSPECTIVE STUDY AT A SINGLE CENTER

  1982cited by this paper
• Effect of Cyclosporin A on the in Situ Inflammatory Response of Human Renal Allograft Rejection

  1982cited by this paper
• Histamine secretion: Research in retrospect

  1982cited by this paper
• Immune system as a target organ for toxicity.

  1982cited by this paper
• D-Penicillamine therapy in progressive systemic sclerosis (scleroderma): a retrospective analysis.

  1982cited by this paper
• [Granulocytotoxic antibodies in levamisole-induced agranulocytosis].

  1982cited by this paper
• Effects of Lodoxamide on Ischemic Reperfused Myocardium

  1982cited by this paper
• Inhibition of the adverse reaction to diethylcarbamazine in Dirofilaria immitis-infected dogs by lodoxamide ethyl.

  1982cited by this paper
• The Use of Cyclosporin A in clinical Organ Grafting

  1982cited by this paper
• The protective effect of lodoxamide on antigen-induced bronchospasm. An orally active antiallergic drug.

  1982cited by this paper
• The synthesis of 6,9-deepoxy-6,9-N-phenylimino-delta 6,8-prostaglandin I1. A novel inhibitor of leukotriene C and D synthesis.

  1982cited by this paper
• Effect of 6,9-deepoxy-6,9-(phenylimino)-delta 6,8-prostaglandin 1(1) (U-60,257), an inhibitor of leukotriene synthesis, on human neutrophil function.

  1982cited by this paper
• A prospective trial of D-penicillamine in primary biliary cirrhosis.

  1982cited by this paper
• Controlled multicenter trial of tiopronin and d-penicillamine for rheumatoid arthritis.

  1982cited by this paper
• Nafazatrom (bay g 6575) inhibition of tumor cell lipoxygenase activity and cellular proliferation

  1982cited by this paper
• Immune regulation in myasthenia gravis: Evidence for an increased suppressor T‐cell population

  1982cited by this paper
• In vitro inhibition of pancreatic B cell function by lymphocytes from diabetics with associated autoimmune diseases: a T cell phenomenon.

  1982cited by this paper
• Leukotriene B4 in synovial fluid

  1982cited by this paper
• Psoriasis and leukotriene B4.

  1982cited by this paper
• Comparison of lodoxamide and cromolyn pretreatment in exercise-challenged asthmatics

  1982cited by this paper
• Treatment of severe aplastic anemia using antithymocyte globulin with or without an infusion of HLA haploidentical marrow.

  1981cited by this paper
• Surface markers of cloned human T cells with various cytolytic activities

  1981cited by this paper
• D-penicillamine treatment improves survival in primary biliary cirrhosis.

  1981cited by this paper
• Effects of in vivo treatments with cyclosporin-A on mouse cell-mediated immune responses.

  1981cited by this paper
• The role of macrophages in the acute-phase response: SAA inducer is closely related to lymphocyte activating factor and endogenous pyrogen.

  1981cited by this paper
• Functional analysis of human T cell subsets defined by monoclonal antibodies. IV. Induction of suppressor cells within the OKT4+ population

  1981cited by this paper
• A novel preparation of human platelet lipoxygenase. Characteristics and inhibition by a variety of phenyl hydrazones and comparisons with other lipoxygenases.

  1981cited by this paper
• Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts.

  1981cited by this paper
• Use of ATG for reversal of acute allograft rejection.

  1981cited by this paper
• Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1).

  1981cited by this paper
• LEUKOTRIENE B4: A MEDIATOR OF VASCULAR PERMEABILITY

  1981cited by this paper
• Prostaglandin E1 inhibits T-cell proliferation and renal disease in MRL/1 mice.

  1981cited by this paper
• Inhibition of oxidative enzymes by anti-allergy drugs.

  1981cited by this paper
• Clinical trial of sulfonated immunoglobulin preparation for intravenous administration

  1981cited by this paper
• Transfer to cyclophosphamide-treated mice of natural killer (NK) cells and in vivo natural reactivity against tumors.

  1981cited by this paper
• Natural killer cells: their roles in defenses against disease.

  1981cited by this paper
• Arachidonic acid metabolism as a source of inflammatory mediators and its inhibition as a mechanism of action for anti-inflammatory drugs

  1981cited by this paper
• Reversal of acute renal allograft rejection with adjunctive AG therapy.

  1981cited by this paper
• Cell-mediated immune assay in children with Schistosoma haematobium infection and the effect of niridazole therapy.

  1981cited by this paper
• INHIBITION OF HUMAN NATURAL KILLER ACTIVITY BY CYCLOSPORIN A

  1981cited by this paper
• Purification to apparent homogeneity of murine interleukin 1.

  1981cited by this paper
• A controlled clinical trial of niridazole in cadaver renal transplantation.

  1980cited by this paper
• Cyclosporin A, transplantation, and lymphoma.

  1980cited by this paper
• Lipoxygenation of arachidonic acid as a source of polymorphonuclear leukocyte chemotactic factors in synovial fluid and tissue in rheumatoid arthritis and spondyloarthritis.

  1980cited by this paper
• Skin transplantation in mice and dogs. Effect of cyclosporin A and dihydrocyclosporin C.

  1980cited by this paper
• Endogenous pyrogens made by rabbit peritoneal exudate cells are identical with lymphocyte-activating factors made by rabbit alveolar macrophages.

  1980cited by this paper
• Inhibition of the release of slow‐reacting substance of anaphylaxis by inhibitors of lipoxygenase activity

  1980cited by this paper
• Malignant lymphoma in cyclosporin A treated allograft recipients.

  1980cited by this paper
• Protective effect opf lodoxamide tromethamine on allergen inhalation challenge.

  1980cited by this paper
• Identification of the C(6)-S-conjugate of leukotriene A with cysteine as a naturally occurring slow reacting substance of anaphylaxis (SRS-A). Importance of the 11-cis-geometry for biological activity.

  1980cited by this paper
• T-cell hybridoma bearing heavy chain variable region determinants producing (T,G)-A--L-specific helper factor

  1980cited by this paper
• THE ACTIVITY OF SODIUM CROMOGLYCATE ANALOGUES IN HUMAN LUNG in vitro: A COMPARISON WITH RAT PASSIVE CUTANEOUS ANAPHYLAXIS AND CLINICAL EFFICACY

  1980cited by this paper
• Use of Levamisole in Viral Infections

  1980cited by this paper
• Leukotriene D: a slow reacting substance from rat basophilic leukemia cells.

  1980cited by this paper
• Effect of cyclosporin A on T-dependent and T-independent immunoglobulin synthesis in vitro

  1980cited by this paper
• Epstein Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in patient with renal allograft.

  1980cited by this paper
• A phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids.

  1980cited by this paper
• Studies on the mechanism of action of cyclosporin A.

  1980cited by this paper
• Prevention of antigen-induced bronchoconstriction by lodoxamide ethyl, a new orally active antiallergic drug.

  1980cited by this paper
• IN VITRO EFFECTS OF CYCLOSPORIN A ON LYMPHOCYTE SUBPOPULATIONS: 1. SUPPRESSOR CELL SPARING BY CYCLOSPORIN A

  1980cited by this paper
• Specific suppression by alloantibodies: passive enhancement.

  1979cited by this paper
• Induction in vitro of reversible immunosuppression and inhibition of B cell receptor regeneration by defined metabolites of cyclophosphamide

  1979cited by this paper
• Antithymocyte globulin (ATGAM) in renal allograft recipients. Multicenter trials using a 14-dose regimen.

  1979cited by this paper
• Suppression of immune complex vasculitis in rats by prostaglandin.

  1979cited by this paper
• Characterization of slow reacting substance as a family of thiolipids derived from arachidonic acid.

  1979cited by this paper
• Natural Killer Cells: Characteristics and Regulation of Activity

  1979cited by this paper
• The requirement for macrophages in the augmentation of natural killer cell activity by BCG.

  1979cited by this paper
• Leukotriene C: a slow-reacting substance from murine mastocytoma cells.

  1979cited by this paper
• Trial of doxantrazole in asthma.

  1979cited by this paper
• Relationship between numbers of beta adrenergic receptors in lymphocytes and disease severity in asthma.

  1979cited by this paper
• Inhibition of the mixed lymphocyte reaction by fractionated niridazole urine dialysate.

  1979cited by this paper
• Immunosuppression for Organ Grafting Observations on Cyclosporin A

  1979cited by this paper
• Manufacture of antithymocyte globulin (ATGAM) for clinical trials.

  1979cited by this paper
• A Double Blind Controlled Trial of N‐(3′, 4′‐Dimethoxycinnamoyl) Anthranilic Acid on Children with Bronchial Asthma

  1979cited by this paper
• Transfer of specific unresponsiveness to organ allografts by thymocytes. Specific unresponsiveness by thymocyte transfer

  1979cited by this paper
• Inhibition of allergic reactions by cromoglycate and by a new anti-allergy drug U-42,585E. I. Activity in rats.

  1978cited by this paper
• Extensive prolongation of rabbit kidney allograft survival after short-term cyclosporin-A treatment.

  1978cited by this paper
• Effect of peripheral blood lymphocytes from patients with aplastic anemia on granulocytic colony growth from HLA-matched and -mismatched marrows: effect of transfusion sensitization.

  1978cited by this paper
• Spontaneous cell-mediated cytotoxicity in humans: role of interferon and immunoglobulins.

  1978cited by this paper
• Enhanced NK cell activity in mice injected with interferon and interferon inducers

  1978cited by this paper
• DOPAMINE-INDUCED ISCHEMIA

  1977cited by this paper
• Suppression of in vivo and in vitro alloimmunity by prostaglandins.

  1977cited by this paper
• New orally effective chromone derivatives for the treatment of asthma

  1977cited by this paper
• Nonrespiratory functions of pulmonary cells: the mast cell.

  1977cited by this paper
• On the structure of slow reacting substance of anaphylaxis: evidence of biosynthesis from arachidonic acid.

  1977cited by this paper
• Treatment of aplastic anaemia by antilymphocyte globulin with and without allogeneic bone-marrow infusions.

  1977cited by this paper

• Definition and History

  1990cites this paper
• In vitro inhibition of prostaglandin production by azathioprine and 6-mercaptopurine.

  1988cites this paper
• Definition und Geschichte

  1986cites this paper